Epilepsy Trends and Future Projections in the Gulf Cooperation Council Region, 1990–2023
Epilepsy burden differs substantially in different parts of the world. Gulf Cooperation Council (GCC) countries have experienced rapid health care changes in recent decades, and there is a lack of epidemiological information based on the specifics of the region. This study intended to assess epilepsy burden changes over time, international disparities, and predict patterns of the disease in the GCC during the time period from 1990 to 2023. Data were extracted from the Global Burden of Disease 2023 dataset for all six GCC member states (Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Bahrain, and Oman). Measures included prevalence and years lived with disability (YLD), expressed as age-standardized rates (ASRs) per 100,000 population. Temporal trends were assessed using percentage change and estimated annual percentage change calculations. Autoregressive integrated moving-average (ARIMA) models forecasted prevalence and YLD rates from 2024 to 2035. From 1990 to 2023, the GCC's age-standardized epilepsy prevalence increased by 10.4%, while YLD rates declined by 17.6%. Saudi Arabia exhibited the highest prevalence increase (18.0%), whereas Qatar and the United Arab Emirates showed the largest declines in YLDs (− 34.6% and − 29.5%, respectively). Forecasts predict a continued gradual rise from 2024 to 2035 in prevalence ASR (796.32 to 963.92) but further declines in disability burden through 2035 (201.01 to 183.47). The GCC region showed considerable improvement in epilepsy-related disability, despite an increase in prevalence; these trends may indicate improvements in diagnosis and treatment and the development of health infrastructure. These gains will have to be consolidated by long-term investments in epilepsy registries, preventive measures, and rehabilitation programs to make sure that the remaining burden is minimized in the region.
Authors
- Kaleem Maqsood (ORCID: https://orcid.org/0000-0003-2330-3162)
- Mahnoor Fatima (ORCID: https://orcid.org/0009-0000-9243-7960)
- Ziyad Althani (ORCID: https://orcid.org/0009-0005-2198-6176)
- Suhailah Hakami
- Mohammed Alshurem (ORCID: https://orcid.org/0000-0002-1861-8218)
- Shahid Bashir (ORCID: https://orcid.org/0000-0001-6286-6895)
- Raidah Albaradie (ORCID: https://orcid.org/0000-0001-7575-7671)
- Ali Mir (ORCID: https://orcid.org/0000-0001-9039-2797)
- Wajd Al Otaibi
- Naif Zahrani
- Sarah Al Wusaibie
- Muhammad Shahid
- Manar Al Otaibi
- Wejdan Al Hakeem
Institutions
- University of the Punjab (PK)
- King Fahad Specialist Hospital (SA)
- Lahore Garrison University (PK)
- Imam Abdulrahman Bin Faisal University (SA)
Publication Details
- Journal
- Avicenna Journal of Medicine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1055/s-0046-1829900
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00